|
US 11,655,459 B2 |
|
| Methods for reprogramming somatic cells |
| Rudolf Jaenisch, Brookline, MA (US); and Konrad Hochedlinger, Cambridge, MA (US) |
| Assigned to Whitehead Institute for Biomedical Research, Cambridge, MA (US) |
| Filed by Whitehead Institute for Biomedical Research, Cambridge, MA (US) |
| Filed on Aug. 29, 2022, as Appl. No. 17/898,360. |
| Application 12/703,061 is a division of application No. 10/997,146, filed on Nov. 24, 2004, granted, now 7,682,828, issued on Mar. 23, 2010. |
| Application 17/898,360 is a continuation of application No. 16/665,821, filed on Oct. 28, 2019. |
| Application 16/665,821 is a continuation of application No. 16/030,815, filed on Jul. 9, 2018, granted, now 10,457,917, issued on Oct. 29, 2019. |
| Application 16/030,815 is a continuation of application No. 15/588,062, filed on May 5, 2017, granted, now 10,017,744, issued on Jul. 10, 2018. |
| Application 15/588,062 is a continuation of application No. 14/923,321, filed on Oct. 26, 2015, granted, now 9,670,464, issued on Jun. 6, 2017. |
| Application 14/923,321 is a continuation of application No. 13/646,430, filed on Oct. 5, 2012, granted, now 9,169,490, issued on Oct. 27, 2015. |
| Application 13/646,430 is a continuation of application No. 12/703,061, filed on Feb. 9, 2010, granted, now 8,940,536, issued on Jan. 27, 2015. |
| Claims priority of provisional application 60/530,042, filed on Dec. 15, 2003. |
| Claims priority of provisional application 60/525,612, filed on Nov. 26, 2003. |
| Prior Publication US 2022/0403344 A1, Dec. 22, 2022 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C12N 15/85 (2006.01); C12N 5/074 (2010.01); A01K 67/027 (2006.01); C07K 14/47 (2006.01); C12N 15/877 (2010.01) |